Neuro-Hitech, Inc.  

(Public, OTCMKTS:NHPI)   Watch this stock  
Find more results for nhpi
0.00010
-0.00005 (-33.33%)
Dec 13 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.00 - 0.00
52 week 0.00 - 0.00
Open 0.00
Vol / Avg. 2.50M/14.70M
Mkt cap 98,140.00
P/E     -
Div/yield     -
EPS -0.02
Shares 31.52M
Beta     -
Inst. own 0%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -53.88% -58.58%
Return on average equity - -4194.20%
Employees 30 -
CDP Score - -

Address

16255 Aviation Loop Dr
BROOKSVILLE, FL 34604-6805
United States - Map
+1-352-7548587 (Phone)
+1-302-6555049 (Fax)

Description

Neuro-Hitech, Inc. is a specialty pharmaceutical company focused on developing, marketing and distributing branded and generic pharmaceutical products primarily in the cough and cold markets. The Company’s principal business is operated through two subsidiaries: MCR American Pharmaceuticals (MCR) and AMBI Pharmaceuticals, Inc. (AMBI). The Company sells its products domestically through United States based distributors. In June 2008, the Company acquired MCR and AMBI. In January 2014, Neuro-Hitech Inc purchased two leases in Ft. Worth Basin in Texas.

Officers and directors

Mark Auerbach CPA, Chairman of the Board
Age: 76
David D Ambrose President, Chief Executive Officer, Director
Age: 46
Reuben Seltzer Vice Chairman of the Board
Age: 57
Gary E. Dutton Jr. Chief Operating Officer, Director
Age: 39
John D. Abernathy Director
Age: 75
David R. Dantzker M.D. Director
Age: 73
Kevin James Esval Director
Age: 49